Skip to main content
SpringerLink
Log in

Medical chemistry for brain function correction

  • Scientific Session of the General Meeting of the Russian Academy of Sciences
  • Published:
Herald of the Russian Academy of Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pharmaceutical Market Trends, 2008–2012 (URCH, 2008).

  2. S. I. Gavrilova, “Pharmacotherapy of Alzheimer’s: AMyth or a Reality?” in Proc. of the 2nd Russian Conf. “Alzheimer’s Disease and Aging: From Neurobiology to Therapy” (Pul’s, Moscow, 1999), pp. 25–44 [in Russian].

    Google Scholar 

  3. V. A. Palyulin, E. V. Radchenko, and N. S. Zefirov, “Molecular Field Topology Analysis Method in QSAR Studies of Organic Compounds,” J. Chem. Inf. Comput. Sci. 40, 659 (2000).

    Google Scholar 

  4. N. M. Halberstam, I. M. Baskin, V. A. Palyulin, and P. S. Zefirov, “Neural Networks as a Method for Elucidating Structure-Property Relationships for Organic Compounds,” Usp. Khim. 72, 706 (2003) [Russ. Chem. Rev. 72, 629 (2003)].

    Google Scholar 

  5. I. I. Baskin, I. G. Tikhonova, V. A. Palyulin, and N. S. Zefirov, “Selectivity Fields: Comparative Molecular Field Analysis (CoMFA) of the Glycine/NMDA and AMPA Receptors,” J. Med. Chem. 46, 4063 (2003).

    Article  Google Scholar 

  6. C. G. Parsons et al., “Memantine: An NMDA Receptor Antagonist That Improves Memory by Restoration of Homeostasis in the Glutamatergic System—Too Little Activation Is Bad, Too Much Is Even Worse,” Neuropharmacology 53, 699 (2007).

    Article  Google Scholar 

  7. M. J. O’Neill and S. Dix, “AMPA Receptor Potentiators as Cognitive Enhancers,” Drugs 10, 185 (2007).

    Google Scholar 

  8. R. P. Sheridan, “The Most Common Chemical Replacements in Drug-Like Compounds,” J. Chem. Inf. Comput. Sci. 42, 103 (2002).

    Google Scholar 

  9. RF Patent No. 2223952 (2004).

  10. S. Bachurin, E. Bukatina, N. Lermontova, et al., “Antihistamine Agent Dimebon as Novel Neuroprotector and Cognition Enhancer,” Ann. New York Acad. Sci. 939, 425 (2001).

    Google Scholar 

  11. S. Doody, S. I. Gavrilova, M. Sano, et al., “Dimebon Improves Cognition, Behavior, Activities of Daily Living, and Global Function in a Randomised, Double-Blind, Placebo-Controlled 6-Month Study of Patients with Mild-to-Moderate Alzheimer’s Disease,” Lancet 372, 207 (2008).

    Article  Google Scholar 

  12. A. Pollak, “Antihistamine Shows Promise in Treating Alzheimer’s,” The New York Times, June 11 (2007).

Download references

Authors
  1. S. O. Bachurin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. S. Zefirov
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Original Russian Text © S.O. Bachurin, N.S. Zefirov, 2010, published in Vestnik Rossiiskoi Akademii Nauk, 2010, Vol. 80, No. 5–6, pp. 497–503.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bachurin, S.O., Zefirov, N.S. Medical chemistry for brain function correction. Her. Russ. Acad. Sci. 80, 279–284 (2010). https://doi.org/10.1134/S1019331610030147

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1019331610030147

Keywords

Search

Navigation